Sanofi Launches Anti-Allergy Dellegra Combination Tablets
This article was originally published in PharmAsia News
Executive Summary
Sanofi launched anti-allergy Dellegra combination tablets, a combination antihistamine drug Allegra and the vasoconstrictor pseudoephedrine, Feb. 28.
Sanofi launched anti-allergy Dellegrac combination tablets, a combination of its second-generation antihistamine drug Allegra (fexofenadine) and the vasoconstrictor pseudoephedrine, Feb. 28, the company announced. The new drug is used to the three main symptoms of sneezing, runny nose, and stuffy nose in allergic rhinitis patients with moderate to severe nasal obstruction. Adults and those over 12 years old take two tablets twice a day on an empty stomach. Tablets are priced at ¥62 each. Formulations with the two components are already widely sold and used by rhinitis patients around the world. (Click Here For More – Japanese Language
)
“Sanofi Launches Anti-Allergy Drug Dellegra Combination Tablets” - mixonline.jp 03/01/2013